Psagot Value Holdings’s Regeneron Pharmaceuticals REGN Stock Holding History

Psagot Value Holdings’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-365	Closed	-$322K	–	447
2023 Q4	$322K	Hold	365	–	–	0.14%	122
2023 Q3	$305K	Hold	365	–	–	0.16%	109
2023 Q2	$259K	Hold	365	–	–	0.13%	138
2023 Q1	$294K	Hold	365	–	–	0.12%	127
2022 Q4	$263K	Hold	365	–	–	0.08%	156
2022 Q3	$251K	Hold	365	–	–	0.07%	157
2022 Q2	$216K	Buy	365 +300	+462%	+$195K	0.05%	183
2022 Q1	$45K	Buy	+65	New	+$41.1K	0.01%	263
2021 Q2	–	Sell	-40	Closed	-$19K	–	497
2021 Q1	$19K	Hold	40	–	–	﹤0.01%	345
2020 Q4	$19K	Hold	40	–	–	﹤0.01%	319
2020 Q3	$22K	Hold	40	–	–	﹤0.01%	356
2020 Q2	$25K	Sell	40 -30	-43%	-$17K	﹤0.01%	327
2020 Q1	$34K	Hold	70	–	–	﹤0.01%	307
2019 Q4	$26K	Hold	70	–	–	﹤0.01%	383
2019 Q3	$19K	Hold	70	–	–	﹤0.01%	364
2019 Q2	$22K	Buy	70 +20	+40%	+$6.66K	﹤0.01%	361
2019 Q1	$21K	Hold	50	–	–	﹤0.01%	393
2018 Q4	$19K	Hold	50	–	–	﹤0.01%	389
2018 Q3	$20K	Hold	50	–	–	﹤0.01%	331
2018 Q2	$17K	Hold	50	–	–	﹤0.01%	305
2018 Q1	$17K	Buy	+50	New	+$17.4K	﹤0.01%	303

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Psagot Value Holdings's REGN Position: Q1 2024 in Review

Psagot Value Holdings sold out of Regeneron Pharmaceuticals (REGN) in Q1 2024, closing a stake of 365 shares — an estimated $322K sold.

Psagot Value Holdings first reported a position in REGN in Q1 2018 and held it in 21 quarters. The position peaked at $322K in Q4 2023. 1,312 funds tracked by Wall St. Rank hold REGN as of Q1 2024.

Psagot Value Holdings reported no remaining Regeneron Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
Psagot Value Holdings sold 365 Regeneron Pharmaceuticals shares in Q1 2024, an estimated $322K.
Psagot Value Holdings first reported a position in Regeneron Pharmaceuticals in Q1 2018 and held it in 21 quarters.
Psagot Value Holdings's Regeneron Pharmaceuticals position peaked at $322K in Q4 2023.
1,312 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2024.

Based on Psagot Value Holdings's 13F filing for Q1 2024, filed 15 May 2024.